These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 5108151)

  • 21. Metabolic fate of 2-methyl-3-o-tolyl-4(3H)-quinazolinone. II. Metabolism of 2-methyl-3-o-tolyl-4(3H)-quinazolinone by rabbits liver.
    Murata T; Yamamoto I
    Chem Pharm Bull (Tokyo); 1970 Jan; 18(1):138-42. PubMed ID: 5417221
    [No Abstract]   [Full Text] [Related]  

  • 22. The metabolic disposition of (S)-2-(3-tert-butylamino-2-hydroxypropoxy)-3-cyanopyridine in rats, dogs, and humans.
    Vickers S; Duncan CA; Arison BH; Davies RO; Ferguson R; Zacchei AG
    Drug Metab Dispos; 1980; 8(3):163-7. PubMed ID: 6104580
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HPLC assay in plasma and preliminary pharmacokinetic study of a quinazolinone derivative with spasmolytic effect.
    Kastner P; Klimes J; Láznícek M; Jira T
    Pharmazie; 2003 Apr; 58(4):242-4. PubMed ID: 12749404
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacology and toxicity of a potent "nonclassical" 2,4-diamino quinazoline folate antagonist, trimetrexate, in normal dogs.
    Weir EC; Cashmore AR; Dreyer RN; Graham ML; Hsiao N; Moroson BA; Sawicki WL; Bertino JR
    Cancer Res; 1982 May; 42(5):1696-702. PubMed ID: 6461409
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics of the new thyrotropin releasing hormone analogue montirelin hydrate. 1st communication: plasma concentrations, metabolism and excretion after a single intravenous administration to rats, dogs and monkeys.
    Sugimoto T; Hayashi T; Okita A; Morino A
    Arzneimittelforschung; 1996 Feb; 46(2):106-13. PubMed ID: 8720298
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Development of tolerance to methyl-o-tolyl-quinazolinone in rats].
    Zilletti L; Perretti F
    Riv Ostet Ginecol; 1969 Jan; 24(1):12-7. PubMed ID: 5404733
    [No Abstract]   [Full Text] [Related]  

  • 27. [Study on the diuretic activity of the 2-phenyl-6-sulfonamido-7-chloro-1,2,3,4-tetrahydro-4-quinazolinone (M.G. 13054)].
    Barbi G; Carenini G; Gentili G; Grumelli E; Milla E
    Farmaco Prat; 1969 Aug; 24(8):496-519. PubMed ID: 5807263
    [No Abstract]   [Full Text] [Related]  

  • 28. [Studies on the resorption and metabolism of the antidepressant 9,9-dimethyl-10-(3-dimethyl-aminopropyl)-acridan-hydrogen tartrate].
    Schatz F; Jahn U; Adrian RW; Molnar I
    Arzneimittelforschung; 1968 Jul; 18(7):862-71. PubMed ID: 5755833
    [No Abstract]   [Full Text] [Related]  

  • 29. Metabolic fate of 2-methyl-3-o-tolyl-4(3H)-quinazolinone. I. 2-nitrobenzo-o-toluidide as an urinary metabolite of 2-methyl-3-o-tolyl-4(3H)-quinazolinone in human.
    Murata T; Yamamoto I
    Chem Pharm Bull (Tokyo); 1970 Jan; 18(1):133-7. PubMed ID: 5417220
    [No Abstract]   [Full Text] [Related]  

  • 30. Metabolism, distribution and excretion of a selective N-methyl-D-aspartate receptor antagonist, traxoprodil, in rats and dogs.
    Prakash C; Cui D; Potchoiba MJ; Butler T
    Drug Metab Dispos; 2007 Aug; 35(8):1350-64. PubMed ID: 17496205
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis and hypolipidemic activities of novel 2-[4-[diethoxyphosphoryl)methyl]phenyl]quinazolines and 4(3H)-quinazolinones.
    Kurogi Y; Inoue Y; Tsutsumi K; Nakamura S; Nagao K; Yoshitsugu H; Tsuda Y
    J Med Chem; 1996 Mar; 39(7):1433-7. PubMed ID: 8691473
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The metabolism of ICI 118,587, a partial agonist of beta 1-adrenoceptors, in mice, rats, rabbits, dogs, and humans.
    Marten TR; Bourne GR; Miles GS; Shuker B; Rankine HD; Dutka VN
    Drug Metab Dispos; 1984; 12(5):652-60. PubMed ID: 6149919
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Physiological disposition and metabolism of O-ethyl-O-4-nitrophenyl phenylphosphonothioate in male cats following a single dermal administration.
    Abou-Donia MB; Kinnes CG; Abdo KM; Bjornsson TD
    Drug Metab Dispos; 1983; 11(1):31-6. PubMed ID: 6132792
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The biotransformation of the immunostimulant 3-(2-mercaptoethyl)quinazoline-2,4(1H,3H)-dione (AWD 100-041)].
    Langner A; Kempa S; Nerlich C; Franke P; Pfeifer S
    Pharmazie; 1994; 49(2-3):169-75. PubMed ID: 8171080
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biotransformation of diphenoxylate in rat and dog.
    Karim A; Garden G; Trager W
    J Pharmacol Exp Ther; 1971 Jun; 177(3):546-55. PubMed ID: 5568810
    [No Abstract]   [Full Text] [Related]  

  • 36. [Synthetic studies of substituted quinazolinone].
    Eguchi Y; Sugimoto A; Ishikawa M
    Tokyo Ika Shika Daigaku Iyo Kizai Kenkyusho Hokoku; 1989; 23():65-72. PubMed ID: 2488965
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Biotransformation of 2-methyl-3-o-tolyl-4-(3H)-quinazolinone (methaqualone)].
    Preuss FR; Hoffmann-Pinther H; Achenbach H; Friebolin H
    Pharmazie; 1970 Dec; 25(12):752-9. PubMed ID: 5499280
    [No Abstract]   [Full Text] [Related]  

  • 38. [Transplacental transfer of methyl-o-tolyl-quinazolinone in rat and its fetal repercussions].
    Perretti F; Zilletti L
    Riv Ostet Ginecol; 1969 Jan; 24(1):1-11. PubMed ID: 5404735
    [No Abstract]   [Full Text] [Related]  

  • 39. Comparison of the metabolism of oltipraz in the mouse, rat and monkey and in man. Distribution of the metabolites in each species.
    Bieder A; Decouvelaere B; Gaillard C; Depaire H; Heusse D; Ledoux C; Lemar M; Le Roy JP; Raynaud L; Snozzi C
    Arzneimittelforschung; 1983; 33(9):1289-97. PubMed ID: 6685510
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metabolism and cardiac actions of a polar aminocardenolide and digoxin in the conscious dog.
    Songu-Mize E; Nash CB; Elam JT; Caldwell RW
    J Pharmacol Exp Ther; 1983 Jul; 226(1):65-70. PubMed ID: 6864551
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.